Three Things The Tech Industry Has Right And The Medical Industry Has Wrong
Dr. Shantanu Gaur recently authored a guest post on TechCrunch on what the medtech industry can learn from the tech industry. Namely, 1) be open with data; 2) create an experience, not just a product; and 3) treat users as participants, not just purchasers. Check out the article here!
Elipse System Receives European Marketing Approval
Today, we are happy to announce that the Elipse System has received European marketing approval! The Elipse Balloon is now available for sale in select centers in Europe. Please read the press release for more details.
Two Gastric Balloons Approved By FDA
In a landmark month for obesity devices, the ReShape Integrated Dual Balloon System and the Orbera Gastric Balloon were both approved by the US FDA for use in obese individuals. While the approval of these two balloons represents a critical step forward for the treatment of obesity in the United States, the devil may be in the details. But first, the good stuff: both balloons have been shown to lead to more weight loss than just dieting in large, well-designed clinical trials. Moreover, participants in the ReShape FDA study who were followed for 6 months after their balloons were removed…
Team Allurion at IFSO 2015
Team Allurion gave a podium presentation at IFSO 2015, hosted its 1st Expert Meeting, and engaged with future Elipse users from all around the world. Thank you to the organizers for a wonderful conference!
Do consumers want weight loss surgery?
Market researchers from Treato recently mined online conversations from around the web to understand consumer sentiment on weight loss surgery. Interestingly, they concluded that 85% of respondents who consider themselves at least 30lbs overweight would not choose weight loss surgery for themselves. These results mirror those from previous studies on consumer preference that concluded that most patients eligible for weight loss surgery would not prefer it. These results highlight an important theme for the overweight and obese market: most consumers do not want weight loss surgery. Several non-surgical options are under development (including gastric balloons) to provide consumers with safe and…
Losing Weight: Diet vs. Exercise
In a recent article in the New York Times, Aaron E. Carroll of the Indiana University School of Medicine argues that eating less is far more important to losing weight than exercising. For example, eliminating two 16-ounce sodas from your diet each day reduces your overall caloric intake by the same amount that 30 minutes of strenuous running would burn. Yet, he argues, our society tends to lend more importance to exercise than portion control for proper weight management. The scientific studies Dr. Carroll cites seem to suggest just the opposite: exercise provides only a small amount of additional weight loss when…
Endoscopic Gastric Balloon Removal: It Ain’t Easy
Many congratulations to ReShape Medical for conducting the first obesity medical device trial in the United States that successfully met its endpoints. The results of the study were published recently in Surgery of Obesity and Related Diseases. One of the many differences between ElipseTM and endoscopic gastric balloons like the ReShape Duo ® is that ElipseTM is procedureless: no endoscopy or anesthesia is required. Here is why that is important. One patient in the ReShape study experienced a torn esophagus that led to bleeding while his ReShape balloon was being removed endoscopically. Another patient also experienced a torn esophagus and required intravenous antibiotics as a…
Allurion Technologies: A Treatment for Obesity That’s Easy to Swallow
Allurion Technologies and the Elipse Balloon were featured in the March issue of Medtech Strategist in an article entitled “Allurion Technologies: A Treatment for Obesity That’s Easy to Swallow”. Thank you to Mary Stuart for a very thoughtful profile of our company and device. Click here to access the article!
Gastric Balloons: Balancing Risk and Reward
A review on gastric balloons co-authored by the Allurion team will be published in the June issue of Gastrointestinal Endoscopy. In this video, senior author Dr. Ram Chuttani discusses the paper’s key findings and their implications for gastric balloons.
Team Allurion at NON INVA 2015
Team Allurion attended and gave two talks at the recent NON INVA conference in Lyon, France. Allurion presented an update on the Elipse System and a recently published review on gastric balloons. We would like to thank the organizers for a wonderful conference!